Literature DB >> 15821662

Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction.

Tamotsu Yasuda1, Richard D Weisel, Chris Kiani, Donald A G Mickle, Manjula Maganti, Ren-Ke Li.   

Abstract

BACKGROUND: Cell transplantation improves heart function after myocardial infarction. This study investigated the survival of implanted cells in normal and infarcted myocardium.
METHODS: Male rat aortic smooth muscle cells were cultured. For the in vitro study, male smooth muscle cells mixed with female smooth muscle cells or male smooth muscle cells injected into a piece of female rat myocardium were used to evaluate the accuracy of quantitative real-time polymerase chain reaction to measure Y chromosomes. For the in vivo study, 2 million live or dead male smooth muscle cells were injected into normal or infarcted female myocardium. At 1 hour and 1 and 4 weeks after transplantation, hearts, lungs, and kidneys were harvested for measurement of Y chromosomes.
RESULTS: In vitro, the accuracy of polymerase chain reaction measurement was excellent in cultured cells (r2 = 0.996) and the myocardium (r2 = 0.786). In vivo, 1 hour after 2 x 10(6) cell implantation, live cell numbers decreased to 1.0 +/- 0.2 x 10 6 and 1.1 +/- 0.3 x 10(6) , and dead cell numbers decreased to 0.9 +/- 0.2 x 10(6) and 0.8 +/- 0.2 x 10(6) in the normal and infarcted myocardium, respectively (P < .01 for all groups). Lungs and kidneys contained 8.5% and 1.5% of the implanted cells, but no cells were detected at 1 week. At 1 week, no dead smooth muscle cells were detected in the normal or infarcted myocardium. The numbers of live cells at 1 and 4 weeks were 0.48 +/- 0.06 x 10(6) and 0.27 +/- 0.07 x 10(6) in normal myocardium and 0.29 +/- 0.08 x 10(6) and 0.18 +/- 0.05 x 10(6) in infarcted myocardium.
CONCLUSIONS: One hour after implantation, only 50% of smooth muscle cells remained in the implanted area. Some implanted cells deposited in other tissue. Implanted cell survival progressively decreased during the 4-week study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821662     DOI: 10.1016/j.jtcvs.2004.06.027

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  21 in total

1.  Synthetic matrices to serve as niches for muscle cell transplantation.

Authors:  Sarah Fernandes; Shannon Kuklok; Joe McGonigle; Hans Reinecke; Charles E Murry
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

Review 2.  Systems approaches to preventing transplanted cell death in cardiac repair.

Authors:  Thomas E Robey; Mark K Saiget; Hans Reinecke; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

3.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

4.  Externally Applied Static Magnetic Field Enhances Cardiac Retention and Functional Benefit of Magnetically Iron-Labeled Adipose-Derived Stem Cells in Infarcted Hearts.

Authors:  Jian Wang; Bo Xiang; Jixian Deng; Hung-Yu Lin; Dayang Zheng; Darren H Freed; Rakesh C Arora; Ganghong Tian
Journal:  Stem Cells Transl Med       Date:  2016-07-08       Impact factor: 6.940

5.  Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts.

Authors:  Nicolas Christoforou; Behzad N Oskouei; Paul Esteso; Christine M Hill; Jeffrey M Zimmet; Weining Bian; Nenad Bursac; Kam W Leong; Joshua M Hare; John D Gearhart
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

6.  Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability.

Authors:  Jianjun Guan; Yi Hong; Zuwei Ma; William R Wagner
Journal:  Biomacromolecules       Date:  2008-03-07       Impact factor: 6.988

7.  Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention.

Authors:  Maria E Danoviz; Juliana S Nakamuta; Fabio L N Marques; Leonardo dos Santos; Erica C Alvarenga; Alexandra A dos Santos; Ednei L Antonio; Isolmar T Schettert; Paulo J Tucci; Jose E Krieger
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Effect of a simple versus a complex matrix on the polarity of cardiomyocytes in culture.

Authors:  Rachel A Davis; W Barry van Winkle; L Maximilian Buja; Brian J Poindexter; Roger J Bick
Journal:  J Burns Wounds       Date:  2006-03-30

9.  Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Authors:  Eugen Kolossov; Toktam Bostani; Wilhelm Roell; Martin Breitbach; Frank Pillekamp; Jens M Nygren; Philipp Sasse; Olga Rubenchik; Jochen W U Fries; Daniela Wenzel; Caroline Geisen; Ying Xia; Zhongju Lu; Yaqi Duan; Ralf Kettenhofen; Stefan Jovinge; Wilhelm Bloch; Heribert Bohlen; Armin Welz; Juergen Hescheler; Sten Eirik Jacobsen; Bernd K Fleischmann
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

10.  Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold.

Authors:  Juliana S Nakamuta; Maria E Danoviz; Fabio L N Marques; Leonardo dos Santos; Claudia Becker; Giovana A Gonçalves; Paula F Vassallo; Isolmar T Schettert; Paulo J F Tucci; Jose E Krieger
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.